Published in Cancer Treat Rev on December 01, 1989
Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA (2010) 10.97
Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2009) 2.78
A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2009) 1.29
Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice. J Clin Oncol (2014) 1.21
Dosimetric verification using monte carlo calculations for tissue heterogeneity-corrected conformal treatment plans following RTOG 0813 dosimetric criteria for lung cancer stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2012) 0.97
An orthotopic lung tumor model for image-guided microirradiation in rats. Radiat Res (2010) 0.96
New era of radiotherapy: an update in radiation-induced lung disease. Clin Radiol (2013) 0.87
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry. J Radiat Oncol (2015) 0.78
Disparities in treatment of patients with inoperable stage I non-small cell lung cancer: a population-based analysis. J Thorac Oncol (2015) 0.75
Radiotherapy and chemotherapy for inoperable non-small cell lung cancer. Postgrad Med J (1995) 0.75
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60
Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare. J Clin Oncol (2001) 2.43
Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. J Clin Oncol (2000) 1.92
Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol (1999) 1.68
Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg (1996) 1.52
Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer (1992) 1.45
2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol (2000) 1.43
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum (1997) 1.41
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol (1999) 1.39
Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. Ann Oncol (2007) 1.38
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum (2000) 1.32
Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys (2001) 1.30
Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg (1990) 1.24
Morphometric analysis of the translocation of lumenal membrane between cytoplasm and cell surface of transitional epithelial cells during the expansion-contraction cycles of mammalian urinary bladder. J Cell Biol (1978) 1.21
Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys (1998) 1.20
The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer (1992) 1.18
Stage I rectal cancer: identification of high-risk patients. J Am Coll Surg (1998) 1.17
Long-term functional results of coloanal anastomosis for rectal cancer. Am J Surg (1994) 1.15
All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum (1999) 1.12
Combined modality chemoradiation in elderly oesophageal cancer patients. Br J Cancer (2007) 1.11
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol (2011) 1.10
T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg (2000) 1.08
The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007. Ann Oncol (2008) 1.01
High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Int J Radiat Oncol Biol Phys (1998) 0.97
High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer. Int J Radiat Oncol Biol Phys (2000) 0.95
Proctectomy and coloanal reconstruction for rectal cancer. Dis Colon Rectum (1990) 0.94
Adjuvant therapy for rectal cancer--a good first step. N Engl J Med (1997) 0.91
Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers. Int J Colorectal Dis (2002) 0.90
Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopy. Int J Colorectal Dis (1991) 0.90
The role of radiation therapy in the control of pain from pancreatic carcinoma. J Pain Symptom Manage (1988) 0.90
Adjuvant therapy for colorectal cancer. Curr Probl Surg (1997) 0.88
Dosimetry of aqueous 32P after soft-tissue infiltration following attempted intravenous administration. Health Phys (1987) 0.87
Conservative management of rectal cancer with local excision and postoperative adjuvant therapy. Int J Radiat Oncol Biol Phys (1999) 0.85
30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy. J Surg Oncol (1999) 0.85
Characterization of malignant colon tumors with 31P nuclear magnetic resonance phospholipid and phosphatic metabolite profiles. Cancer (1995) 0.83
The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: results of the 1992-1994 Patterns of Care Study. Cancer (1999) 0.83
Sucrase-isomaltase is an independent prognostic marker for colorectal carcinoma. Dis Colon Rectum (1995) 0.81
X-ray-mediated cross linking of protein and DNA. Radiat Res (1977) 0.81
The use of a prosthetic tissue expander to displace bowel from a brachytherapy implant site. Int J Radiat Oncol Biol Phys (1990) 0.81
Conservative management of rectal cancer with local excision and adjuvant therapy. Oncology (Williston Park) (2001) 0.79
Aggressive surgical management of locally advanced primary and recurrent rectal cancer. Current status and future directions. Dis Colon Rectum (1990) 0.78
Meningioma phospholipid profiles measured by 31P nuclear magnetic resonance spectroscopy. Lipids (1994) 0.78
A phase I trial of preoperative radiation, proctectomy, and endoanal reconstruction. Arch Surg (1990) 0.78
Esophageal cancer phospholipids correlated with histopathologic findings: a 31P NMR study. NMR Biomed (1999) 0.78
Results after rectal cancer resection with in-continuity partial vaginectomy and total mesorectal excision. Ann Surg Oncol (2003) 0.77
Esophageal cancer phospholipid characterization by 31P NMR. NMR Biomed (1993) 0.77
Blood vessel invasion in colorectal cancer--an alternative to TNM staging? Ann Surg Oncol (1999) 0.77
Patterns of care study decision tree and management guidelines for esophageal cancer. American College of Radiology. Radiat Med (1999) 0.77
Leiomyosarcoma of the anus treated with sphincter-preserving surgery and radiation therapy. J Surg Oncol (1986) 0.75
Sphincter preservation in rectal cancer-continued evidence of success. Int J Radiat Oncol Biol Phys (2000) 0.75
Intracavitary birdcage resonator: applications to the human prostate. J Magn Reson Imaging (1995) 0.75
A birdcage resonator for intracavitary MR imaging. Magn Reson Imaging (1993) 0.75
Sphincter preservation of leiomyosarcoma of the rectum and anus with local excision and brachytherapy. Dis Colon Rectum (1999) 0.75
Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.75
Effect of a collagen substrate on the growth and development of normal and tumorigenic rat urothelial cells. J Urol (1983) 0.75
Induction chemotherapy for non-small cell lung cancer with clinically evident mediastinal node metastases: the role of postoperative radiotherapy. Int J Radiat Oncol Biol Phys (1992) 0.75
31P NMR phospholipid characterization of intracranial tumors. Brain Res (1994) 0.75
Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin. Oncology (Williston Park) (2000) 0.75
Sphincter preservation in rectal cancer. Introduction. Semin Radiat Oncol (1998) 0.75
Rectal cancer: presentation with metastatic and locally advanced disease. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.75
Locally unresectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.75
Anal cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.75